Mounjaro 2.5 mg
This product is used for the primary treatment of type 2 diabetes, providing continuous release of 2.5 mg of active substance for seven days.
- The description claims continuous afgifte (release) for seven days.
AI Readiness
Good foundation, but some important product data is still missing.
74%